ESC Premium Access

Novel imaging and risk stratification of acute pulmonary embolism

Event: ESC CONGRESS 2019
Topic: Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
Session type: Moderated Posters
Date: 3 September 2019
Time: 10:05 - 10:55

Congress Session

7 presentations in this session

Usefulness of different electrocardiographic patterns as predictors of in-hospital mortality in acute pulmonary embolism.

Speaker: Doctor P. Alarcon (Buenos Aires, AR)

Factors associated with a negative D-dimer test in patients diagnosed with acute symptomatic pulmonary embolism

Speaker: Doctor S. Barco (Zurich, CH)

Prognosis of pulmonary embolism 30-day mortality risk based on five admission parameters: the PoPE score

Speaker: Doctor D. Candeias Faria (Amadora, PT)

Derivation and validation of a new probability score in pulmonary embolism suspicion allowing safely reduction of imaging testing: PEPS (Pulmonary Embolism Probability Score)

Speaker: Professor P. Roy (Angers, FR)

Modified CT-based Bova score may improve the classification of patients with acute pulmonary embolism at risk of adverse events

Speaker: Ms M. Skowronska (Warsaw, PL)

Hypoperfusion markers identify patients with acute pulmonary embolism at highest risk for an adverse outcome

Speaker: Doctor M. Ebner (Berlin, DE)

Dual-energy CT was effective to evaluate of microvasculopathy in chronic thromboembolic pulmonary hypertension

Speaker: Doctor H. Onishi (Kobe, JP)

7 speakers from this session

Doctor Pamela Alarcon

Hospital Universitario Austral, Buenos Aires (Argentina)
0 follower

Doctor Stefano Barco

University Hospital Zurich, Zurich (Switzerland)
0 follower

Doctor Daniel Alexandre Candeias Faria

Hospital Prof Fernando da Fonseca EPE, Amadora (Portugal)
2 presentations
1 follower

Professor Pierre-Marie Roy

University Hospital of Angers, Angers (France)
2 presentations
0 follower

Ms Marta Skowronska

Medical University of Warsaw, Warsaw (Poland)
0 follower

Doctor Matthias Ebner

Charite University Hospital, Berlin (Germany)
0 follower

Doctor Hiroyuki Onishi

Kobe University Graduate School of Medicine, Kobe (Japan)
0 follower

This platform is supported by

logo Novo Nordisk